Cargando…
The comparison of the effectiveness and safety of drospirone ethinyl estradiol and ethinyl estradiol cyproterone in the treatment of polycystic ovarian syndrome: A protocol for systematic review and meta-analysis
BACKGROUND: Polycystic ovarian syndrome (PCOS) is an endocrine disorder syndrome with reproductive dysfunction and abnormal glucose metabolism. Persistent non-ovulation, excessive androgens and insulin resistance are important features and they are the most common causes of menstrual disorders in wo...
Autores principales: | Liu, Zhimin, Song, Ying, Xu, Yuanfang, Wang, Jing, Hu, Hongyuan, Weng, Yingchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748340/ https://www.ncbi.nlm.nih.gov/pubmed/33371158 http://dx.doi.org/10.1097/MD.0000000000023811 |
Ejemplares similares
-
Experimental Hepatotoxicity Produced by Ethinyl estradiol
por: Pandey, Govind, et al.
Publicado: (2011) -
Flutamide versus a cyproterone acetate-ethinyl estradiol combination in moderate acne: a pilot randomized clinical trial
por: Adalatkhah, Hassan, et al.
Publicado: (2011) -
The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg
por: Krishnan, Sheila, et al.
Publicado: (2010) -
The New Extended-Cycle Levonorgestrel-Ethinyl Estradiol Oral Contraceptives
por: Bonnema, Rachel A., et al.
Publicado: (2011) -
Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne
por: Tan, Jerry KL, et al.
Publicado: (2010)